Fennec Pharmaceuticals Inc.

8-K Shareholder vote results Jun 10, 2026 8-K Other events May 22, 2026 8-K Director or officer change May 18, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Director or officer change Apr 28, 2026 8-K Other events Apr 22, 2026 8-K Other events Apr 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Mar 24, 2026 8-K Other events Mar 16, 2026 8-K Other events Mar 4, 2026 8-K Other events Feb 20, 2026 8-K Other events Dec 9, 2025 8-K Other events Dec 2, 2025 8-K Entered a material agreement; Other events Nov 19, 2025 8-K Entered a material agreement; Other events Nov 18, 2025 8-K Entered a material agreement; Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Shareholder vote results Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 26, 2025 8-K Results of operations (earnings release) Mar 10, 2025 8-K Other events Feb 7, 2025 8-K Other events Dec 20, 2024 8-K Entered a material agreement; Other events Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Director or officer change; Other events Oct 30, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Director or officer change; Other events Aug 7, 2024 8-K Director or officer change; Other events Jul 2, 2024 8-K Shareholder vote results Jun 25, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Other events May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Results of operations (earnings release) Mar 25, 2024 8-K Entered a material agreement; Other events Mar 21, 2024 8-K/A Results of operations (earnings release) Mar 6, 2024 8-K Other events Feb 29, 2024 8-K Other events Feb 2, 2024